Treatment of hypertension with 1-tert.-butylamino-3-(2,5-dichlorophenoxy)-2-propanol
US4310549A · kind A · utility
4Cited by
1References
1Claims
0Family size
Inventors
Key dates
| Filing date | Sep 4, 1979 |
| Grant date | Jan 12, 1982 |
| Priority date | — |
| Expiry date | Sep 4, 1999 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/5375
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
1-tert.-butylamino-3-(2,5-dichlorophenoxy)-2-propanol and its pharmaceutically acceptable acid addition salts possess hypotensive and bradycardizing effects. Thus they can be applied in human therapy for the treatment of hypertension and simultaneously also of tachycardia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.